PharmaBoardroom

Currently, what are the main priorities and goals of ISPAT related to the Healthcare and Pharmaceuticals sector, and what are the overall strategies…

Poland and Turkey present many similarities, in terms of market size and frequency of reforms for instance, but also a lot of differences, as the…

What were the first challenges you have faced as the new General Manager of Celgene turkey? In all humility, I have to say that even though it is…

Can you describe the current investment climate in Turkey for pharma companies? Turkey’s economic and political situation are very important…

The company entered the Turkish market in 2005, and made important product launches in 2008. You have been General Manager of Ferring Turkey over…

Mr. Krýza, Mr. Nádvorník, between the two of you, you have over 21 years of experience at Cegedim, and have watched this company…

Mr. Krýza, Mr. Nádvorník, between the two of you, you have over 21 years of experience at Cegedim, and have watched this company…

Would you like to come back for our readers on the main milestones in Daiichi Sankyo’s development over the past few years in Turkey and how it…

Ms. Hauser, you represent what is perhaps the last major generation of medical doctors in this country that left the medical field to join the…

Mr. Krejčí, can you please begin with a broad introduction to Ewopharma, for those of our readers who are unfamiliar with the company?…

As the founder of SMD what was it the prompted you to create this company and what were your objectives at that time? Up until 2003 when I created…

As the first Ukrainian pharmaceutical company backed by foreign capital, explain to us how the idea of creating “Sperco Ukraine” as a…